Red Biotechnology Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Gene Therapy Products, Vaccines, Cell Therapy Products, Blood Products, Diagnostic Reagents), By Application (Biopharmaceutical Production, Gene Therapy, Drug Discovery & Development, Genetic Testing, Pharmacogenomics, Stem Cell Research, Others), By End-user (Pharmaceutical & Biotechnology Companies, Research & Academic Institutions, Contract Research Organizations (CROs), Hospitals & Clinics, Diagnostic Laboratories, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jul 2025 | Report ID: MI3217 | 219 Pages


Report Coverage:

By Product Type

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Gene Therapy Products
  • Vaccines
  • Cell Therapy Products
  • Blood Products
  • Diagnostic Reagents

By Application

  • Biopharmaceutical Production
  • Gene Therapy
  • Drug Discovery & Development
  • Genetic Testing
  • Pharmacogenomics
  • Stem Cell Research
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutions
  • Contract Research Organizations (CROs)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Biogen Inc.
  • Gilead Sciences, Inc.
  • Sanofi
  • Regeneron Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Bayer AG

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.